<DOC>
	<DOCNO>NCT00854217</DOCNO>
	<brief_summary>Several study highlight cardioprotective effect acute normovolemic hemodilution cardiac surgery . The aim study show increase endogenous erythropoietin ( EPO ) might explain cardioprotective effect acute normovolemic hemodilution ischemia-reperfusion phenomenon .</brief_summary>
	<brief_title>Cardioprotective Effects Endogenous Erythropoietin Patients Undergoing Coronary Artery Bypass Surgery</brief_title>
	<detailed_description>The major physiologic function EPO think induction erythropoiesis . However , grow body evidence indicate EPO tissue-protective effect prevents tissue damage ischemia . In ex vivo proof-of-concept , protective effect EPO show human myocardium . Several study demonstrate acute normovolemic hemodilution aortic cross clamp decrease perioperative myocardial damage . We hypothesize onset acute anemia increase endogenous EPO concentration , explain cardioprotective effect acute normovolemic hemodilution .</detailed_description>
	<criteria>patient 18 80 year old undergoing CABG without cardiopulmonary bypass emergency redo operation combine surgery men Hb &lt; 120g/dL woman Hb &lt; 110g/ dL patient preoperative creatinine &gt; 2.2 mg/dL poor ventricular function ( EF &lt; 50 % ) subject pulmonary disease , hepatic disease subject carotid stenosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>